Ryboquin raises £1.8m for drug development in gene therapy – Drug Target Review
Drug Target Review |
Ryboquin raises £1.8m for drug development in gene therapy
Drug Target Review Ryboquin Limited announces that it has closed a £1.8m equity fund raising to accelerate product development in gene therapy. Tycoons fund biotech firm with ambitions to ‘revolutionise’ cancer …Herald Scotland |
Shanghai Daily (subscription) |
Effective component in ginseng successfully cultivated
Shanghai Daily (subscription) “Synthetic biology is an interdisciplinary branch of biology and engineering. It has become a very popular topic in the science field,” said Wang Yong from the Institute of Plant Physiology and Ecology and vice director of synthetic biology key … |
National Post |
Canadian clinics begin offering stem–cell treatments experts call unproven, possibly unsafe
National Post The 63-year-old says the stem cells she received at Regenervate Medical Injection Therapy 18 months ago were transformational, all but eliminating the debilitating soreness and even allowing her to hike Argentina’s Patagonia mountains two months ago. |